AN-2690
An antifungal compound that inhibits cytoplasmic leucyl-tRNA synthetase for the potential treatment of nnychomycosis; inhibits T. rubrum, T. mentagrophytes, C. albicans, C. neoformans with MIC50s of 0.25-1ug/mL. (In Vitro) :Tavaborole (AN-2690) shows an 8-fold increase in activity against C. neoformans, and an 8-fold increase in activity against A. fumigatus. Tavaborole (AN-2690) obviously inhibit the cells expressing GlLeuRS-D444A, but has no effect on the cells expressing GlLeuRS and GlLeuRS-D444E.
Product Specifications
CAS Number
174671-46-6
Product Name Alternative
Tavaborole | AN2690 | AN 2690
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
OB1OCC2=CC (F) =CC=C12
Molecular Formula
C7H6BFO2
Molecular Weight
151.9307
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Bacillus cereus Riboflavin biosynthesis protein ribBA (ribBA)
Recombinant Bacillus cereus Riboflavin biosynthesis protein ribBA (ribBA)
Recombinant Bacillus cereus Riboflavin biosynthesis protein ribBA (ribBA)
Recombinant Bacillus cereus Riboflavin biosynthesis protein ribBA (ribBA)
Recombinant Bacillus cereus Riboflavin biosynthesis protein ribBA (ribBA)